Regulation of Sequential Protein Kinase Pathways
Regulation of Sequential Protein Kinase Pathways
批准号:
8038148
负责人:
GARY L. JOHNSON
金额:
$10.14万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2011-03-31
关键词:
AblationAnimalsAntibodiesBackBindingBiological AssayBiological FactorsBiological ModelsBlood VesselsBreast Cancer CellBreast Fat PadCancer cell lineCell CommunicationCell LineCell NucleusCell membraneCell physiologyCellsChromatinChronicComplexCultured CellsDataData SetDatabasesDevelopmentDiseaseEGF geneEndosomesEnhancersExtracellular MatrixFOS geneFamilyFatty acid glycerol estersFibroblastsFocal AdhesionsFundingGene ExpressionGene TargetingGenesGenetic TranscriptionGoalsGrantGranulocyte-Macrophage Colony-Stimulating FactorHomeostasisHumanHypoxiaIL8 geneImage AnalysisImmigrationImmunoblottingIn VitroInflammationInjection of therapeutic agentIschemiaJUN geneLaboratoriesLeast-Squares AnalysisLeft ventricular structureLibrariesLocationLungMAP3K1 geneMAP3K7 geneMAPK11 geneMAPK14 geneMAPK7 geneMAPK8 geneMCF7 cellMEKKsMammalian CellMammary glandMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesMeasurementMeasuresMetalloproteasesMetricMitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesModelingMusNeoplasm MetastasisOutputPathway AnalysisPathway interactionsPeptide HydrolasesPhenotypePhosphotransferasesPhysiologicalPhysiologyPlacentaPlayPrimary NeoplasmPromoter RegionsPropertyProtease GeneProtein FamilyProtein KinaseProteinsRNA InterferenceReceptor GeneRegulationResearch PersonnelRoleSerineSignal PathwaySignal TransductionSiteSmall Interfering RNAStimulusStromal Cell-Derived Factor 1SystemTailTestingThreonineTimeTissuesTranscription Factor AP-1Tumor Cell LineUbiquitinationUnited States National Institutes of HealthUrokinaseUrokinase Plasminogen Activator ReceptorVascular Endothelial Growth FactorsVeinsWorkbasebonecell growthcytokinedrug discoveryfos-related antigen-2human diseasein vivoknockout genemalignant breast neoplasmmatrigelmembermigrationmodel developmentneoplastic cellpromoterprotein expressionreceptorreceptor expressionresearch studyresponsesmall hairpin RNAsoft tissuespatiotemporaltooltranscription factortumortumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mitogen activated protein kinases (MAPKs) are serine-threonine protein kinases that play critical roles in
regulating cellular homeostasis. MAPKs are members of a three kinase relay system composed of the
MARK, MARK kinase (MKK) and MARK kinase kinase (MKKK). Four MARK families, ERK1/2, p38, JNK and
ERK5 are members of an integrated MARK signaling network. There are 7 MKKs but at least 20 MKKKs in
the MARK signaling network. We have made gene knockouts to ablate expression or knockins to inactivate
the kinase activity of four MKKKs (MEKK1, 2, 3, 4). Ablation or kinase inhibition of each MEKK results in a
unique physiological phenotype in the mouse. Different MEKKs were found to regulate neurulation, vascular
and placenta! development, and dissemination of tumor cells during metastasis, tissue remodelingfollowing
ischemia or hypoxia, and specific aspects of chronic inflammation. The hypothesis of the current proposal is
that MKKKs differentially integrate the activation of specific MAPKs in cellular responses to diverse stimuli.
Despite the importance of MARK signaling networks in cell and animal physiology there is no comprehensive
understanding of how different MKKKs coordinately regulate the MARK network for cellular homeostasis.
We have shown that RNAi faithfully recapitulates targeted gene knockout of MKKKs in cells. Therefore,to
define the function of MKKKs, an RNAi screen to ablate expression of a test set of 8 MKKKs that have
particular relevance in control of homeostasis, will be performed in four human breast cancer cell lines. The
aims of the proposal will define: 1. The functional consequence of MKKK knockdown on the signaling
dynamics of the MARK network. 2. Role of MKKKs in the spatiotemporal activation of ERK1/2, JNK, p38 and
ERK5. 3. To understand the transcriptional mechanism for changes in cytokine and protease expression
resulting from specific MKKK knockdown. 4. To analyze the consequence of specific MKKK knockdown on
orthotopic tumor cell growth and metastasis. 5. From these data a multivariate model based on Partial Least
Squares will be developed to define the function of specific MKKKs in controlling signaling networks and
physiological outputs. The creation of this systems-level model, along with iterative cycling between model
and experiment, will allow us to define the function of specific MKKKs in controlling signaling networks
related to tumor cell phenotype including metastasis-related physiological outputs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Illuminating Function of the Understudied Druggable Kinome
-
批准号:10251291
-
项目类别:
-
资助金额:$225.18万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:9762097
-
项目类别:
-
资助金额:$226.6万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:9453342
-
项目类别:
-
资助金额:$230.82万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
Illuminating Function of the Understudied Druggable Kinome
-
批准号:10015261
-
项目类别:
-
资助金额:$225.92万
-
财政年份:2017
-
负责人:GARY L. JOHNSON
-
依托单位:
The adaptive kinome in pancreatic cancer
-
批准号:8859584
-
项目类别:
-
资助金额:$57.37万
-
财政年份:2015
-
负责人:GARY L. JOHNSON
-
依托单位:
Activation and Regulation of the Understudied Kinome Using MIB/MS Technology
-
批准号:9120936
-
项目类别:
-
资助金额:$39.51万
-
财政年份:2014
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8457042
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8273335
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
-
批准号:8607578
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2012
-
负责人:GARY L. JOHNSON
-
依托单位:
Molecular Therapeutics
-
批准号:8340206
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2011
-
负责人:GARY L. JOHNSON
-
依托单位:
Receptor Interaction with GTP-Regulatory Proteins
-
批准号:7867340
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2009
-
负责人:GARY L. JOHNSON
-
依托单位:
Function of MEKK3 and its osmosensing scaffold protein
-
批准号:7889368
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2009
-
负责人:GARY L. JOHNSON
-
依托单位:
Defining Signal Network Plasticity
-
批准号:7498599
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2008
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7608096
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2007
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7378108
-
项目类别:
-
资助金额:$2.08万
-
财政年份:2006
-
负责人:GARY L. JOHNSON
-
依托单位:
Inhibitor Screens for Five MAPK Kinase Kinases Important in Human Disease
-
批准号:7169344
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2006
-
负责人:GARY L. JOHNSON
-
依托单位:
EFFICACY OF COORDINATED SUPPORTIVE CARE IN GYNECOLOGIC ONCOLOGY PATIENTS
-
批准号:7203341
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2005
-
负责人:GARY L. JOHNSON
-
依托单位:
UNC Center for Nanosensing the Stressome (RMI)
-
批准号:6930731
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2004
-
负责人:GARY L. JOHNSON
-
依托单位:
Efficacy of Coordinated Supportive Care in Gynecologic Oncology Patients
-
批准号:6981289
-
项目类别:
-
资助金额:$2.78万
-
财政年份:2004
-
负责人:GARY L. JOHNSON
-
依托单位:
Function of MEKK3 and its osmosensing scaffold protein
-
批准号:8123425
-
项目类别:
-
资助金额:$31.14万
-
财政年份:2003
-
负责人:GARY L. JOHNSON
-
依托单位:
海外基金